Abstract:Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer mortality worldwide. Total laparoscopic pancreaticoduodenectomy (TLPD) have been used in the treatment of benign and low-grade diseases on the pancreatic head. It is necessary to expand the current knowledge on the feasibility and safety of TLPD for PDAC treatment. We aimed to assess the surgical and oncological outcomes of TLPD for patients with PDAC by comparing them with open pancreaticoduodenectomy (OPD). Methods Data regarding patients who underwent pancreaticoduodenectomy for PDAC treatment from January 2013 to January 2019 in our hospital were obtained. Baseline characteristics, intraoperative effects, postoperative recoveries, and survival outcomes were compared. To overcome selection bias, we performed a 1:1 match using propensity score matching (PSM) between TLPD and OPD. We also conducted a systematic review and meta-analysis. Results The original cohort included 276 patients (TLPD; 98 patients, OPD; 178 patients). After PSM, there were 89 patients in each group and the patient demographics were well matched. Of the 98 patients who underwent TLPD, 8 (8.2%) required conversions to laparotomies. Compared to OPD, TLPD could be performed with longer operative times, had less blood loss, and had lower overall morbidities. Regarding oncological and survival outcomes, there were no significant differences in tumor size, R0 resection rates and tumor stages between groups. However, TLPD had an advantage over OPD in terms of retrieved lymph nodes (21.9 ± 6.6 vs. 18.9 ± 5.4, p < 0.01). There were no statistically signiﬁcant differences between the groups in recurrence patterns, and the 3-year recurrence-free and overall survival rates were comparable between the two groups. Meta-analysis further confirmed that the TLPD were associated with longer operative times, less blood loss, shorter hospitalizations, lower morbidities, and a greater number of retrieved lymph nodes. Conclusions TLPD are feasible and oncologically safe procedures for PDAC treatments. Postoperative outcomes and long-term survival after TLPD are superior, or not inferior, to OPD, and could be a promising alternative to open surgery for PDAC treatments. Our findings should be further evaluated by multicenter or randomized controlled trials.

Radical resection benefits patients suffering pancreatic ductal adenocarcinoma with liver oligometastases

Expanding Laparoscopic Pancreaticoduodenectomy to Pancreatic-Head and Periampullary Malignancy: Major Findings Based on Systematic Review and Meta-Analysis

Perioperative Outcomes Comparing Laparoscopic with Open Repeat Liver Resection for Post-Hepatectomy Recurrent Liver Cancer: A Systematic Review and Meta-Analysis

Laparoscopic Versus Open Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis

Laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic outcomes and long-term survival

LDP vs ODP for pancreatic adenocarcinoma: a case matched study from a single-institution

Total Laparoscopic Versus Open Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: a Propensity Score Matching Analysis with Meta-Analysis

[Strategy in Management of Adjacent Organ Lesion During Laparoscopic Pancreaticoduodenectomy].

Dose Surgical Resection of Hepatic Metastases Bring Benefits to Pancreatic Ductal Adenocarcinoma? A Systematic Review and Meta-Analysis.

Laparoscopic Versus Open Pancreatic Resection for Ductal Adenocarcinoma: Separate Propensity Score Matching Analyses of Distal Pancreatectomy and Pancreaticoduodenectomy.

Feasibility of Pancreaticoduodenectomy with Synchronous Liver Metastasectomy for Oligometastatic Pancreatic Ductal Adenocarcinoma - A Case-Control Study

Effect of Radical Lymphadenectomy in Colorectal Cancer with Para-Aortic Lymph Node Metastasis: a Systematic Review and Meta-Analysis

Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries

Clinical outcome comparison of laparoscopic radical antegrade modular pancreatosplenectomy vs. laparoscopic distal pancreatosplenectomy for left-sided pancreatic ductal adenocarcinoma surgical resection

Prognostic Significance of Radical Surgical Treatment for Gastric Cancer Patients with Synchronous Liver Metastases

Resection of Liver Metastases: A Treatment Provides a Long-Term Survival Benefit for Patients with Advanced Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis

Optimal Extent of Lymphadenectomy for Radical Surgery of Pancreatic Head Adenocarcinoma: A Single-center, Prospective, Randomized Controlled Study

Patients with Hepatic Oligometastatic Pancreatic Body/tail Ductal Adenocarcinoma May Benefit from Synchronous Resection

Optimal Extent of Lymphadenectomy for Radical Surgery of Pancreatic Head Adenocarcinoma

Dose surgical resection of hepatic metastases bring benefits to pancreatic ductal adenocarcinoma? A systematic review and meta-analysis

Laparoscopic Pancreaticoduodenectomy with Portal or Superior Mesenteric Vein Resection and Reconstruction for Pancreatic Cancer: A Single-Center Experience.